Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at ...
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
3d
HealthDay on MSNFour Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALSFour immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophi ...
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...
JRMC undergraduate students as well as AUCTV and graduate students from the Kamal Adham Center received several awards at media and film festivals in Egypt.
While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...
A new study published in the recent issue of Journal of American Medical Association found that the usage of verdiperstat, a ...
3d
HealthDay on MSNBlood Test Can Help Diagnose, Track ALSA blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease ...
3d
Medpage Today on MSNNovel Agent Safe in ALS, Phase II Study SuggestsTetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results